674298-03-4

Basic information

• Product Name: N¹,N⁹-bis-1,1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl-N⁵-(3-carboxypropanoyl)-norspermidine
• Synonyms: N¹,N⁹-bis-1,1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl-N⁵-(3-carboxypropanoyl)-norspermidine
• CAS NO: 674298-03-4
• Molecular Weight: 559.703
• Mol File: 674298-03-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: N¹,N⁹-bis-1,1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl-N⁵-(3-carboxypropanoyl)-norspermidine(CAS DataBase Reference)
• NIST Chemistry Reference: N¹,N⁹-bis-1,1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl-N⁵-(3-carboxypropanoyl)-norspermidine(674298-03-4)
• EPA Substance Registry System: N¹,N⁹-bis-1,1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl-N⁵-(3-carboxypropanoyl)-norspermidine(674298-03-4)

Safety Data

• Hazardous Substances Data: 674298-03-4(Hazardous Substances Data)

Upstream product

• 94142-97-9 2-(1-hydroxyethylidene)-5,5-dimethylcyclohexane-1,3-dione 
• 56-18-8 bis(3-aminopropyl)amine 
• 108-30-5 succinic acid anhydride 
• 674297-98-4 N¹,N⁹-bis-1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl-norspermidine 

Relevant articles and documents

Cationic lipids

The invention provides a cationic lipid comprising: (i) one head group, comprising one or more amino acids, in which at least one amino acid has a side chain that comprises a cationic moiety or a cationic precursor;(ii) a linking moiety of formula (5): [i

Solid-Phase Synthesis of 89 Polyamine-Based Cationic Lipids for DNA Delivery to Mammalian Cells

The ability of non-viral gene delivery systems to overcome extracellular and intracellular barriers is a critical issue for future clinical applications of gene therapy. In recent years much effort has been focused on the development of a variety of DNA c